| 000 | 01536 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516071844.0 | ||
| 264 | 0 | _c20130805 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1945-0524 | ||
| 024 | 7 |
_a10.2741/278 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalabretta, Bruno | |
| 245 | 0 | 0 |
_aSuppression of autophagy by BCR/ABL. _h[electronic resource] |
| 260 |
_bFrontiers in bioscience (Scholar edition) _c01 2012 |
||
| 300 |
_a453-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
| 650 | 0 | 4 |
_aChloroquine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aSalomoni, Paolo | |
| 773 | 0 |
_tFrontiers in bioscience (Scholar edition) _gvol. 4 _gno. 2 _gp. 453-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2741/278 _zAvailable from publisher's website |
| 999 |
_c21422092 _d21422092 |
||